FTSE All-Share 998184 / GB0031758641
5’266.90
Pkt
45.92
Pkt
0.88
%
17:40:33
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu FTSE All-Share-Werten
| 07.02.24 | BP Buy | UBS AG | |
| 07.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | BP Overweight | Barclays Capital | |
| 06.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 06.02.24 | BP Outperform | RBC Capital Markets | |
| 06.02.24 | BP Hold | Jefferies & Company Inc. | |
| 06.02.24 | GSK Buy | UBS AG | |
| 06.02.24 | Vodafone Group Buy | UBS AG | |
| 06.02.24 | BP Buy | UBS AG | |
| 05.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 05.02.24 | Shell Buy | Jefferies & Company Inc. | |
| 05.02.24 | BP Outperform | RBC Capital Markets | |
| 05.02.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 05.02.24 | GSK Buy | Deutsche Bank AG | |
| 05.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 05.02.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 05.02.24 | National Grid Buy | Jefferies & Company Inc. | |
| 02.02.24 | Glencore Equal Weight | Barclays Capital | |
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | HSBC Holdings Overweight | Barclays Capital | |
| 02.02.24 | Shell Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Buy | Jefferies & Company Inc. | |
| 01.02.24 | Diageo Underperform | RBC Capital Markets | |
| 01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 01.02.24 | Shell Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Glencore Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Neutral | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG |